References
- Golub, T.R. and Arceci, R.J. (2002) "Acute myelogenous leukemia", In: Pizzo, P.A. and Poplack, D.G., eds, Principles and Practices of Pediatric Oncology, 4th Ed. (Lippincott Williams and Wilkins, Philadelphia) pp 545–589.
- Bloomfield, C.D. and Caligiuri, M.A. (2001) "Leukemias", In: DeVita, V.T., Jr, Hellman, S. and Rosenberg, S.A., eds, Principles and Practice of Oncology, 6th Ed. (Lippincott Williams and Wilkins, Philadelphia) pp 2389–2509.
- Appelbaum, ER., Rowe, J.M., Radich, J. and Dick, J.E. (2001) "Acute myeloid leukemia", In: Schechter, G., Broudy, V. and Williams, M., eds, Hematology 2001: Education Program Book of the American Society of Hematology Annual Meeting (Orlando, 2001) (American Society of Hematology, Washington) pp 62–86.
- Gorin, N.C., Estey, E., Jones, R.J., Jones, R.J., Levitsky, H.I., Borrello, I. and Slavin, S. (2000) "New development in the therapy of acute myelocytic leukemia", In: Schechter, G.P., Berliner, N. and Telen, Mi., eds, Hematology 2000: Education Program Book of the American Society of Hematology Annual Meeting (San Francisco, 2000) (American Society of Hematology, Washington) pp 69–89.
- Cheson, B.D., Vena, D.A., Foss, F.M. and Sorensen, J.M. (1994) "Neurotoxicity of purine analogs: a review", Journal of Clinical Oncology 12(10), 2216–2228.
- Cones, J.E., Gandhi, V., Plunkett, W., Keating, M., Faderl, S., O'Brien, S., Giles, F., Garcia-Manero, G., Thomas, D., Du, M., Davis, J., Craig, A., Estey, E. and Kantarjian, H. (2002) "Clofarabine (2-chloro-9-(2-deoxy-2-fluoro-13-D-arabinofuranosyl)adenine } is active for patients with refractory or relapsed acute leukemias, myelodysplastic syndromes (MDS) and chronic myeloid leukemia in blast phase (CML-BP)", Blood 100\(Suppl. 1), 197a.